Lantus Versus Levemir Treat-To-Target

PHASE4CompletedINTERVENTIONAL
Enrollment

973

Participants

Timeline

Start Date

November 30, 2006

Primary Completion Date

June 30, 2008

Conditions
Diabetes Mellitus, Type 2
Interventions
DRUG

Insulin glargine

Subcutaneous injection, once a day in the evening

DRUG

Insulin Detemir

Subcutaneous injection, twice a day at breakfast and before dinner

Trial Locations (20)

Unknown

Sanofi-Aventis, North Ryde

Sanofi-Aventis, São Paulo

Sanofi-Aventis, Laval

Sanofi-Aventis, Hoersholm

Sanofi-Aventis, Helsinki

Sanofi-Aventis, Berlin

Sanofi-Aventis, Mumbai

Sanofi-Aventis, Dublin

Sanofi-Aventis, Gouda

Sanofi-Aventis, Porto Salvo

Sanofi-Aventis, Bucharest

Sanofi-Aventis, Moscow

Sanofi-Aventis, Belgrade

Sanofi-Aventis, Seoul

Sanofi-Aventis, Barcelona

Sanofi-Aventis, Stockholm

Sanofi-Aventis, Meyrin

Sanofi-Aventis, Taipei

Sanofi-Aventis, Istanbul

Sanofi-Aventis, Guildford

Sponsors

Lead Sponsor

All Listed Sponsors
lead

Sanofi

INDUSTRY

NCT00405418 - Lantus Versus Levemir Treat-To-Target | Biotech Hunter | Biotech Hunter